show episodes
 
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
 
Clinical research and clinical trial management form the backbone of drug and device approvals worldwide. Learn from the leading industry experts to build and advance your clinical research career. You'll hear from sponsors, clinical research organizations, and clinical trial sites around the globe. This show is for all current and aspiring clinical research professionals including clinical research associates (CRA), clinical operations managers, study managers, biostatisticians, medical doc ...
 
With more than 100 cancer care providers, Minnesota Oncology offers access to the latest evidence-based treatment paths, 12 close-to-home locations in the Twin Cities Metro area, and comprehensive services to support the whole person. In this podcast, experts from Minnesota Oncology and our community of care discuss the latest topics in oncology treatments, research, support, caregiving, and more. Treating cancer takes a community. Welcome to ours. Visit: https://mnoncology.com
 
I'm Aware That I'm Rare: the phaware® podcast is devoted to raising global pulmonary hypertension awareness with dynamic stories from PH patients, caregivers and medical professionals from around the world. Through this series of impactful, insightful and, most importantly, hopeful stories from members of the global pulmonary hypertension community, we hope to further the global #phaware conversation as well as to capture, engage and enable misdiagnosed and undiagnosed PH patients because ea ...
 
Loading …
show series
 
Rosemary Kennedy is the Chief Health Information Officer at Connect America, where data collection, predictive analytics, remote monitoring, human intervention, and promotion of patient care circles are all part of the solution for keeping seniors out of the hospital and independent as possible. Rosemary explains, "There are probably three areas in…
 
Rosemary Kennedy is the Chief Health Information Officer at Connect America, where data collection, predictive analytics, remote monitoring, human intervention, and promotion of patient care circles are all part of the solution for keeping seniors out of the hospital and independent as possible. Rosemary explains, "There are probably three areas in…
 
Andy Kidd MD is the President and COO and soon to be CEO of Aptinyx. With a focus on Pain Awareness Month, Andy provides a view into the world of treating long-term chronic pain and the necessary innovations to treat the cause of chronic pain in conditions like diabetic peripheral neuropathy and fibromyalgia. Andy explains, "So we've discovered and…
 
Andy Kidd MD is the President and COO and soon to be CEO of Aptinyx. With a focus on Pain Awareness Month, Andy provides a view into the world of treating long-term chronic pain and the necessary innovations to treat the cause of chronic pain in conditions like diabetic peripheral neuropathy and fibromyalgia. Andy explains, "So we've discovered and…
 
Cardiac arrest care, finerenone, carotids, meds post TAVI: less is more and the new may not be as grand as the tried and true. John Mandrola, MD, provides a third ESC review. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I - Cardiac Arrest Care - Angiography Can Wait for Cardiac Arrest Without ST-Elevation https:/…
 
Jessica Magana is the Product Manager of Lightbeam Health Solutions, a population health management company. Jessica shines a light on the biggest changes coming from CMS in risk adjustment for Medicare Advantage in 2022. Organizations need to understand the technical requirements behind the way diagnosed base risk scores will be calculated and the…
 
Jessica Magana is the Product Manager of Lightbeam Health Solutions, a population health management company. Jessica shines a light on the biggest changes coming from CMS in risk adjustment for Medicare Advantage in 2022. Organizations need to understand the technical requirements behind the way diagnosed base risk scores will be calculated and the…
 
Dr. Hugh Rienhoff is the Founder and Chief Executive Officer at Imago BioSciences. He and his team are developing their lead asset bomedemstat for the treatment of myeloproliferative neoplasms (MPNs) which are rare blood cancers. Hugh explains, "So MPNs, myeloproliferative neoplasms, are actually a family of diseases that include myelofibrosis, pol…
 
Dr. Hugh Rienhoff is the Founder and Chief Executive Officer at Imago BioSciences. He and his team are developing their lead asset bomedemstat for the treatment of myeloproliferative neoplasms (MPNs) which are rare blood cancers. Hugh explains, "So MPNs, myeloproliferative neoplasms, are actually a family of diseases that include myelofibrosis, pol…
 
ESC Wrap-up Part II: EMPEROR-Preserved, and the STEP, Guide-HF, and IAMI trials, are discussed by John Mandrola, MD, in this week’s podcast. To read a partial transcript or to comment, visit: https://www.medscape.com/twic I - HFpEF - EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough https://www.medscape.com/viewarticle/957405 - Empaglifloz…
 
Eric Rock is the Founder and CEO of Vivify Health and a pioneer in the application of remote patient monitoring, consumer electronics, and biometric devices combined with virtual visits to connect patients and providers outside the hospital setting. Eric explains, "Fortunately, Vivify, from our beginning days, created a solution that encompassed a …
 
Eric Rock is the Founder and CEO of Vivify Health and a pioneer in the application of remote patient monitoring, consumer electronics, and biometric devices combined with virtual visits to connect patients and providers outside the hospital setting. Eric explains, "Fortunately, Vivify, from our beginning days, created a solution that encompassed a …
 
Craig Parker is the Chief Executive Officer at Surrozen. Their research in the Wnt pathway and proteins identified these are critical to maintaining tissues in our body and are found in tissues as diverse as the lung, intestine, liver, sensory hair cells, and the eye. The company is first targeting a patient population with a severe alcoholic injur…
 
Craig Parker is the Chief Executive Officer at Surrozen. Their research in the Wnt pathway and proteins identified these are critical to maintaining tissues in our body and are found in tissues as diverse as the lung, intestine, liver, sensory hair cells, and the eye. The company is first targeting a patient population with a severe alcoholic injur…
 
Dr. Richard Watson is a Co-Founder of Motient and has taken on the challenge of creating an efficient solution to solve the puzzle of how to move patients from one place to another with a focus on rural healthcare and rural hospitals. Motient was founded as a medical transport company that did air and ground transport. They have now created Mission…
 
Dr. Richard Watson is a Co-Founder of Motient and has taken on the challenge of creating an efficient solution to solve the puzzle of how to move patients from one place to another with a focus on rural healthcare and rural hospitals. Motient was founded as a medical transport company that did air and ground transport. They have now created Mission…
 
EMPEROR-Preserved, the LOOP study, ablate-and-pace for AF, and salt substitute and stroke: John Mandrola, MD provides a first of two ESC reviews. To read a partial transcript or to comment, visit: https://www.medscape.com/twic 1 - HFpEF - EMPEROR-Preserved: Empagliflozin Scores HFpEF Breakthrough https://www.medscape.com/viewarticle/957405 - Empagl…
 
David Katz is the Chief Scientific Officer at Sparrow Pharmaceuticals. He is exploring the possibility of blocking the formation of intracellular steroids to reduce the side effects of steroid medicines and conditions related to the overproduction of cortisol in the body in such diseases as Cushing's Syndrome and autonomous cortisol secretion. Davi…
 
David Katz is the Chief Scientific Officer at Sparrow Pharmaceuticals. He is exploring the possibility of blocking the formation of intracellular steroids to reduce the side effects of steroid medicines and conditions related to the overproduction of cortisol in the body in such diseases as Cushing's Syndrome and autonomous cortisol secretion. Davi…
 
Dr. Bierer is the Director of the Regulatory Foundations, Ethics and the Law Program of the Harvard Clinical and Translational Science Center and the Director of Regulatory Policy, SMART IRB. Previously she served as senior vice president, research, at the Brigham and Women’s Hospital for 11 years, and was the institutional official for human and a…
 
Hideki Garren MD Ph.D. is the Chief Medical Officer at Prothena with a mission to advance the pipeline of candidates for neurodegenerative and protein amyloid diseases, including Alzheimer's and Parkinson's. We talk about the recent FDA approval of aducanumab and its impact on research. Hideki says, "As we've shown at the AAIC, the Alzheimer's Asso…
 
Hideki Garren MD Ph.D. is the Chief Medical Officer at Prothena with a mission to advance the pipeline of candidates for neurodegenerative and protein amyloid diseases, including Alzheimer's and Parkinson's. We talk about the recent FDA approval of aducanumab and its impact on research. Hideki says, "As we've shown at the AAIC, the Alzheimer's Asso…
 
Karen Chen is the Chief Executive Officer of the Spinal Muscular Atrophy Foundation. With a background in drug development having worked in pharma and biotech in neurodegenerative diseases like Alzheimer's and Parkinson's, Karen brings a deep understanding of the value of treating rare diseases that are genetically defined. Karen explains, "The fou…
 
Karen Chen is the Chief Executive Officer of the Spinal Muscular Atrophy Foundation. With a background in drug development having worked in pharma and biotech in neurodegenerative diseases like Alzheimer's and Parkinson's, Karen brings a deep understanding of the value of treating rare diseases that are genetically defined. Karen explains, "The fou…
 
Loading …

Quick Reference Guide

Copyright 2021 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login